SANDESH SETH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for SANDESH SETH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SANDESH SETH. SANDESH SETH is a CEO in Actinium Pharmaceuticals, Inc. ($ATNM) and a Chairman & CEO in Actinium Pharmaceuticals, Inc. ($CTVN) and a Chairman and CEO in Actinium Pharmaceuticals, Inc. ($CTVN) and an Chief Executive Officer in Actinium Pharmaceuticals, Inc. ($ATNM) and a Director in Actinium Pharmaceuticals, Inc. ($CTVN) and an Executive Chairman in Actinium Pharmaceuticals, Inc. ($CTVN) and a Director in RELMADA THERAPEUTICS, INC. ($RLMD).
Address: 300 E 93RD STREET, #20-B NEW YORK 10128 NY
Companies in which SANDESH SETH is an Insider
Actinium Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SANDESH SETH: Chief Executive Officer, Chairman & CEO, Chairman and CEO, Director, Executive Chairman
Holdings: 161,458 shares
Latest Transaction: Aug 14 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
RELMADA THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SANDESH SETH: Director
Holdings: 123,258 shares
Current Value: $134,351
Latest Transaction: Dec 17 2015
$RLMD Market Capitalization: $12.16M
$RLMD Previous Close: $1.09
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of SANDESH SETH
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 14 2020 | ATNM | Actinium Pharmaceu ... | SETH SANDESH | Chief Executive Off ... | Option Exercise | A | 9.55 | 139,062 | 1,328,042 | 139,062 | |
| Jul 16 2019 | ATNM | Actinium Pharmaceu ... | SETH SANDESH | CEO | Option Exercise | A | 0.23 | 1,500,000 | 348,000 | 1,500,000 | |
| Feb 21 2019 | ATNM | Actinium Pharmaceu ... | SETH SANDESH | Chairman & CEO | Buy | X | 0.60 | 8,125 | 4,875 | 161,458 | 153.3 K to 161.5 K (+5.30 %) |
| Feb 21 2019 | ATNM | Actinium Pharmaceu ... | SETH SANDESH | Chairman & CEO | Buy | X | 0.60 | 8,125 | 4,875 | 161,458 | 153.3 K to 161.5 K (+5.30 %) |
| Dec 10 2018 | ATNM | Actinium Pharmaceu ... | SETH SANDESH | Chairman & CEO | Buy | P | 0.44 | 10,000 | 4,372 | 153,333 | 143.3 K to 153.3 K (+6.98 %) |
| Jul 17 2018 | ATNM | Actinium Pharmaceu ... | SETH SANDESH | CEO | Option Exercise | A | 0.78 | 1,000,000 | 782,900 | 1,000,000 | |
| Jul 17 2018 | ATNM | Actinium Pharmaceu ... | SETH SANDESH | CEO | Buy | P | 0.79 | 10,000 | 7,900 | 143,333 | 133.3 K to 143.3 K (+7.50 %) |